Table 3. SF-36v2 scores. Values are median (range).
| Baseline(n = 25) | 3 months(n = 21) | 6-months(n = 17) | P | |
| Control group | ||||
| PF | 52 (5—95) | 74 (10–95) | 80 (25–100) | 0.001 |
| RP | 43 (0—100) | 45 (0–100) | 52 (0–100) | ns |
| BP | 46 (0–100) | 82 (22–100) | 85 (52–100) | 0.003 |
| GH | 68 (10–97) | 71 (20–92) | 67 (27–87) | ns |
| VT | 50 (0–93) | 61 (12–100) | 63 (0–100) | ns |
| SF | 71 (12–100) | 84 (37–100) | 80 (0–100) | ns |
| RE | 67 (0–100) | 63 (0–100) | 65 (0–100) | ns |
| MH | 62 (10–100) | 74 (25–100) | 74 (10–100) | 0.03 |
| Experimental group | (n = 25) | (n = 18) | (n = 13) | |
| PF | 56 (5–100) | 65 (5–95) | 66 (0–100) | ns |
| RP | 44 (0–100) | 51 (0–100) | 58 (6–100) | ns |
| BP | 51 (10–100) | 71 (22–100) | 77 (22–100) | 0.004 |
| GH | 63 (16–100) | 68 (45–92) | 72 (42–92) | ns |
| VT | 42 (0–93) | 52 (6–81) | 55 (6–81) | ns |
| SF | 59 (25–100) | 72 (25–100) | 75 (25–100) | ns |
| RE | 63 (0–100) | 68 (0–100) | 71 (25–100) | ns |
| MH | 56 (5–100) | 65 (10–95) | 75 (40–100) | 0.04 |
PF = physical functioning, RP = role physical, BP = bodily pain, GH = general health, VT = vitality, SF = social functioning, RE = role emotional, MH = mental health. Only showing significant p values (Friedman analyses) ns = not significant.